Roth Capital Downgrades Inovio Pharmaceuticals (INO) to Sell

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. SNDK
6. HTFL
7. ADYEN:NA
8. ADYYF
9. WDAY
10. DVLT

July 1, 2020 7:48 AM EDT
Get Alerts INO Hot Sheet
Price: $1.09 +21.11%

Rating Summary:
    11 Buy, 5 Hold, 2 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE

Roth Capital analyst Jonathan Aschoff downgraded Inovio Pharmaceuticals (NASDAQ: INO) from Neutral to Sell with a price target of $11.00.


For an analyst ratings summary and ratings history on Inovio Pharmaceuticals click here. For more ratings news on Inovio Pharmaceuticals click here.


Shares of Inovio Pharmaceuticals closed at $25.00 yesterday.


You May Also Be Interested In





Related Categories

Downgrades